1. Home
  2. INDP vs YQ Comparison

INDP vs YQ Comparison

Compare INDP & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • YQ
  • Stock Information
  • Founded
  • INDP 2000
  • YQ 2012
  • Country
  • INDP United States
  • YQ China
  • Employees
  • INDP N/A
  • YQ N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • INDP Health Care
  • YQ Real Estate
  • Exchange
  • INDP Nasdaq
  • YQ Nasdaq
  • Market Cap
  • INDP 8.8M
  • YQ 14.9M
  • IPO Year
  • INDP N/A
  • YQ 2020
  • Fundamental
  • Price
  • INDP $0.79
  • YQ $1.94
  • Analyst Decision
  • INDP Strong Buy
  • YQ
  • Analyst Count
  • INDP 2
  • YQ 0
  • Target Price
  • INDP $8.50
  • YQ N/A
  • AVG Volume (30 Days)
  • INDP 19.4K
  • YQ 8.6K
  • Earning Date
  • INDP 03-17-2025
  • YQ 03-19-2025
  • Dividend Yield
  • INDP N/A
  • YQ N/A
  • EPS Growth
  • INDP N/A
  • YQ N/A
  • EPS
  • INDP N/A
  • YQ N/A
  • Revenue
  • INDP N/A
  • YQ $28,507,378.00
  • Revenue This Year
  • INDP N/A
  • YQ N/A
  • Revenue Next Year
  • INDP N/A
  • YQ N/A
  • P/E Ratio
  • INDP N/A
  • YQ N/A
  • Revenue Growth
  • INDP N/A
  • YQ 22.55
  • 52 Week Low
  • INDP $0.70
  • YQ $1.50
  • 52 Week High
  • INDP $3.10
  • YQ $3.19
  • Technical
  • Relative Strength Index (RSI)
  • INDP 48.01
  • YQ 52.29
  • Support Level
  • INDP $0.76
  • YQ $1.93
  • Resistance Level
  • INDP $0.86
  • YQ $2.01
  • Average True Range (ATR)
  • INDP 0.06
  • YQ 0.06
  • MACD
  • INDP 0.01
  • YQ -0.01
  • Stochastic Oscillator
  • INDP 69.81
  • YQ 40.63

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.

Share on Social Networks: